ESC 365
ESC 365
Sign in

    Back

    Welcome and introduction.

    30 August 2021 (15:00 - 15:05)
    Organised by:
    Congress Presentation Part of: Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial. Atrial Fibrillation (AF) Open Access ESC Congress 2021 - The Digital Experience

    About the speaker

    Photo
    Doctor Shigeru Saito

    Shonan Kamakura General Hospital, Kamakura (Japan)

    3 More presentations in this session

    Presentation thumbnail
    Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.
    Professor N. van Mieghem (Rotterdam, NL)
    Presentation thumbnail
    New developments in NOACs and TAVI: How do we apply them in clinical practice?
    Professor D. Capodanno (Catania, IT)
    Presentation thumbnail
    Panel discussion.

    Access the full session

    Session thumbnail
    Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.
    Video

    The Event

    Event poster

    ESC Congress 2021 - The Digital Experience

    30 August 2021 15:00 CET
    You may be interested in
    thumbnail
    Congress Session
    Treatment strategies for atrial fibrillation in heart failure
    Logo
    thumbnail
    Congress Session
    EHRA Myths - Device-detected atrial fibrillation
    Logo
    thumbnail
    Congress Session
    Stroke prevention in clinical and subclinical atrial fibrillation
    Logo